Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway.
Saved in:
| Title: | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway. |
|---|---|
| Authors: | Dugbartey, George J., Wonje, Quinsker L., Alornyo, Karl K., Robertson, Louis, Adams, Ismaila, Boima, Vincent, Mensah, Samuel D. |
| Source: | Frontiers in pharmacology 3/24/2022; Vol. 13. |
| Journal Info: | Publisher: Frontiers Media S.A. ISSN: 1663-9812 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
